RecruitingNCT05777681
Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
30 participants
Start Date
Oct 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Aortic infection
- Mycotic Aneurysm
- Aortic Graft Infection
Exclusion Criteria1
- Absence of signs of infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREAortic Surgery
open surgical repair with resection of infected aortic segment, debridement of surrounding tissue and in situ graft replacement.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05777681
Related Trials
INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
NCT068164859 locations
Use of Shockwave M5+/L6 IVL Catheter (Intravascular Lithotripsy) in Hostile and Calcified Iliac Access
NCT058806416 locations
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
NCT073229133 locations
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
NCT0707838323 locations
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
NCT0400597620 locations